The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: C-Reactive Protein, Cardio CRP, Cardio hs-CRP, CRP, High Sensitivity CRP, High-sensitivity C-reactive Protein, High-sensitivity CRP, Highly Sensitive CRP, hsCRP, Ultra-sensitive CRP
Also known as: Lipid Panel with Ratios (fasting), Lipid Profile with Ratios (fasting), Lipids
The CVD-1. High Cholesterol Testing panel contains 2 tests with 8 biomarkers.
Brief Description: The CVD-1 High Cholesterol Testing panel is an essential set of screenings designed to evaluate cardiovascular health and risk factors associated with heart disease. This panel includes tests for high-sensitivity C-Reactive Protein (hs-CRP) and a comprehensive Lipid Panel with Ratios. It serves as a foundational tool for identifying individuals at risk for cardiovascular disease (CVD), particularly those related to cholesterol levels and inflammation, which are significant contributors to heart disease.
Collection Method: Blood Draw
Specimen Type: Serum
Test Preparation: Patient should be fasting 9-12 hours prior to collection.
The CVD-1 High Cholesterol Testing panel may be ordered as part of a routine health check-up, especially for individuals with a family history of heart disease, high cholesterol, or other risk factors such as hypertension, diabetes, obesity, or smoking. It is also commonly recommended for individuals who have already been diagnosed with heart disease or have experienced events such as heart attacks or strokes, to monitor the effectiveness of treatment and lifestyle modifications.
hs-CRP: This test measures the level of high-sensitivity C-reactive protein in the blood, which can indicate inflammation in the body. Elevated hs-CRP levels are associated with an increased risk of cardiovascular disease, as inflammation plays a significant role in the development of atherosclerosis (the buildup of plaque in the arteries).
Lipid Panel with Ratios: This comprehensive test measures total cholesterol, HDL cholesterol ("good" cholesterol), LDL cholesterol ("bad" cholesterol), and triglycerides. It also includes ratios such as the total cholesterol to HDL ratio, which can provide further insight into cardiovascular risk. The lipid panel is a crucial component in assessing the risk of heart disease and guiding treatment decisions.
For individuals seeking a more detailed assessment of their cardiovascular health, moving beyond the CVD-1 High Cholesterol Testing panel to the more comprehensive panels like CVD-2, CVD-3, and CVD-4 can provide deeper insights and more specific risk stratification.
CVD-2 High Cholesterol Testing Panel
The CVD-2 panel builds upon CVD-1 by adding Apolipoprotein A1, Apolipoprotein B, Lipoprotein (a), Cardio IQ™ Lipoprotein Fractionation, Ion Mobility, and VLDL Cholesterol tests. These additional tests offer a more nuanced view of lipoprotein particles and their subclasses, which can be crucial in understanding individual risk factors and tailoring more specific treatment strategies.
CVD-3 High Cholesterol Testing Panel
Further expanding on CVD-2, the CVD-3 panel includes Direct LDL and LP-PLA2 Activity tests. Direct LDL provides a more accurate measurement of low-density lipoprotein cholesterol, crucial for individuals with high triglyceride levels. LP-PLA2 Activity is a marker of vascular inflammation, offering additional risk assessment for cardiovascular events.
CVD-4 High Cholesterol Testing Panel
The CVD-4 panel is the most comprehensive, incorporating the Cardio IQ™ ApoE Genotype test. This genetic test can provide information on an individual's genetic predisposition to developing high cholesterol and cardiovascular disease, allowing for highly personalized treatment and preventive strategies.
The CVD-1 High Cholesterol Testing panel is instrumental in detecting and managing conditions related to cardiovascular health:
Cardiovascular Disease: Elevated cholesterol levels, particularly LDL cholesterol, and inflammation as indicated by hs-CRP, are significant risk factors for the development of heart disease, including coronary artery disease and stroke.
Inflammatory Conditions: An elevated hs-CRP level can also suggest systemic inflammation, which may be linked to a variety of conditions beyond cardiovascular disease, including infections and chronic inflammatory diseases.
Healthcare professionals use the results from the CVD-1 High Cholesterol Testing panel to:
Guide Treatment for High Cholesterol: Depending on the lipid panel results, treatment may involve lifestyle changes, such as diet and exercise, and medications like statins to lower cholesterol levels.
Assess Cardiovascular Risk: Elevated hs-CRP levels, in conjunction with lipid panel results, can help in assessing the risk of cardiovascular events, guiding preventive strategies and interventions.
The CVD-1 High Cholesterol Testing panel offers a fundamental evaluation of key factors contributing to cardiovascular health, including cholesterol levels and inflammation. It serves as a critical tool for early detection, risk assessment, and the guidance of treatment strategies to prevent heart disease. For those looking to delve deeper into their cardiovascular health, the subsequent panels—CVD-2, CVD-3, and CVD-4—provide expanded testing for a more comprehensive risk assessment and personalized approach to cardiovascular health management.
We advise having your results reviewed by a licensed medical healthcare professional for proper interpretation of your results.